N/A
N=13
Resilience Intervention for Older, HIV-Infected Women
Resilience, Psychological
Bottom Line
View on ClinicalTrials.gov: NCT03071887 ↗Enrolled (actual)
13
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcome: Primary: Number of Participants Completing Treatment Sessions — 4; 9 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Relaxation Response Resiliency Program (3RP) (Behavioral)
- Age
- Adult, Older Adult · 50+ yrs
- Sex
- Female
- Sponsor
- Massachusetts General Hospital
- Primary completion
- Aug 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Completing Treatment Sessions |
4; 9 | — |
| PRIMARY Participant Satisfaction With Study Procedures |
6; 1 | — |
Summary
The goal of this study is to refine and pilot the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging and living with chronic disease. The investigators will adapt the 3RP resiliency intervention to the needs of this population and conduct preliminary testing of the group intervention via an open pilot study.
Eligibility Criteria
Inclusion Criteria
- biologically born women who endorse a female identity
- HIV-infected
- age 50 or older
- English speaking
Exclusion Criteria
- presence of an active (i.e. untreated) and interfering psychiatric disorder (e.g., bipolar disorder, schizophrenia, substance abuse)
- have participated in a structured cognitive behavioral therapy and/or a mind-body intervention in the past year
Data sourced from ClinicalTrials.gov (NCT03071887). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.